gut.bmj2d
Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies
Objective We performed a meta-analysis of observational studies to quantify the magnitude of the association between non-alcoholic fatty liver disease (NAFLD) and risk of extrahepatic cancers. Design ...
gut.bmj2d
Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study
Objective The microbiome contributes to the pathogenesis of inflammatory bowel disease (IBD) but the relative contribution of different lifestyle and environmental factors to the compositional ...
gut.bmj3d
Deep-learning based detection of gastric precancerous conditions
Correspondence to Dr Markus Casper, Department of Medicine II, Saarland University Medical Center, Saarland University, 66421 Homburg, Germany; markus.casper{at}uks.eu Conventional white-light ...
gut.bmj3d
Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice
Objective Faecal microbiota transplantation (FMT) has proved to be an extremely effective treatment for recurrent Clostridioides difficile infection, and there is interest in its potential application ...
gut.bmj3d
Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease
Correspondence to Professor Bernd Schnabl, Department of Medicine, University of California, San Diego, CA 92093, USA; beschnabl{at}ucsd.edu The spectrum of non-alcoholic fatty liver disease (NAFLD) ...
gut.bmj3d
Definition and taxonomy of interval colorectal cancers: a proposal for standardising nomenclature
1 Division of Gastroenterology and Hepatology, Department of Internal Medicine; and GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht The ...
gut.bmj5d
Global incidence of oesophageal cancer by histological subtype in 2012
Correspondence to Dr Melina Arnold, Section of Cancer Surveillance, International Agency for Research on Cancer, 150 Cours Albert Thomas, Lyon 69008, France; arnoldm{at}fellows.iarc.fr Objective The ...
gut.bmj5d
Maternal antibiotic exposure during pregnancy and risk of IBD in offspring: a population-based cohort study
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...
gut.bmj6d
Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study
Correspondence to Julien Kirchgesner, Service de Gastroentérologie et Nutrition, Hôpital Saint-Antoine, Assistance Publique - Hôpitaux de Paris, 184 rue du faubourg Saint-Antoine, Paris 75012, France; ...
gut.bmj6d
Metabolic dysfunction-associated steatotic liver disease in children
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease, is the most common cause of chronic liver disease in children. MASLD ...
gut.bmj7d
Alternative treatments for type 2 diabetes and associated metabolic diseases: medical therapy or endoscopic duodenal mucosal remodelling?
Correspondence to Professor Jacques J G H M Bergman, Gastroenterology and Hepatology, Amsterdam UMC Location AMC, Amsterdam 1105 AZ, The Netherlands; j.j.bergman{at}amsterdamumc.nl Despite important ...
gut.bmj7d
Targeting the gut-liver-immune axis to treat cirrhosis
Cirrhotic portal hypertension is characterised by development of the decompensating events of ascites, encephalopathy, portal hypertensive bleeding and hepatorenal syndrome, which arise in a setting ...